2.374

0.63% -0.016

Cabaletta Bio Inc (CABA)

Overview News Price History Option Chain Financials Why CABA Down? Discussions Forecast

Cabaletta Bio Inc stock is traded at $2.374, with a volume of 417.50K. It is down -0.63% in the last 24 hours and up +14.18% over the past month. Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Previous Close:

$2.39

Open:

$2.4

24h Volume:

417.50K

Relative Volume:

0.10

Market Cap:

$228.63M

Revenue:

Net Income/Loss:

$-67.68M

P/E Ratio:

-1.4301

EPS:

-1.66

Net Cash Flow:

$-54.24M

1W Performance:

-0.63%

1M Performance:

+14.18%

6M Performance:

+32.68%

1Y Performance:

-0.21%

1-Day Range:

$2.36

$2.43

1-Week Range:

$2.32

$2.49

52-Week Range:

$0.9857

$3.67

Cabaletta Bio Inc Stock (CABA) Company Profile

Name

Cabaletta Bio Inc

Sector

Healthcare (1135)

Industry

Biotechnology (633)

Phone

(267) 759-3100

Address

2929 ARCH STREET, PHILADELPHIA, PA

Employee

151

Twitter

@CabalettaBio

Next Earnings Date

2025-03-31

Latest SEC Filings

CABA's Discussions on Twitter

Compare CABA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CABA Cabaletta Bio Inc	2.375	230.07M	0	-67.68M	-54.24M	-1.66
VRTX Vertex Pharmaceuticals Inc	457.85	115.75B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	779.24	80.71B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	410.35	52.88B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	854.28	52.64B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.45	37.29B	447.02M	-1.18B	-906.14M	-6.1812

Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-10-25	Resumed	Jefferies	Buy
Dec-20-24	Downgrade	Evercore ISI	Outperform → In-line
Dec-19-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-10-24	Initiated	UBS	Buy
Feb-05-24	Initiated	Jefferies	Buy
Nov-29-23	Initiated	William Blair	Outperform
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight
Oct-19-23	Initiated	Stifel	Buy
Sep-05-23	Initiated	Citigroup	Buy
Jul-18-23	Initiated	Guggenheim	Buy
Jan-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-30-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-08-21	Initiated	Wells Fargo	Overweight
Oct-19-21	Resumed	Morgan Stanley	Overweight
Jun-30-21	Initiated	Mizuho	Buy
Jan-08-21	Initiated	Chardan Capital Markets	Buy
Oct-13-20	Initiated	H.C. Wainwright	Buy
Nov-19-19	Initiated	Cowen	Outperform
Nov-19-19	Initiated	Evercore ISI	Outperform
Nov-19-19	Initiated	Morgan Stanley	Overweight

View All

Cabaletta Bio Inc Stock (CABA) Latest News

Dec 20, 2025

History Review: Is Cabaletta Bio Inc. stock gaining market shareMarket Volume Summary & Daily Technical Forecast Reports - Улправда

Dec 20, 2025

Update Report: Is Cabaletta Bio Inc. stock gaining market shareProfit Target & Stepwise Trade Signal Guides - ulpravda.ru

Dec 20, 2025

Why Cabaletta Bio Inc. stock remains on watchlistsJuly 2025 Institutional & Weekly High Conviction Trade Ideas - ulpravda.ru

Dec 20, 2025

Sentiment Watch: Will Cabaletta Bio Inc. stock recover faster than marketChart Signals & Weekly Chart Analysis and Trade Guides - ulpravda.ru

Dec 20, 2025

Dec 19, 2025

Will Cabaletta Bio Inc. stock continue upward momentumMarket Rally & Capital Efficiency Focused Ideas - Улправда

Dec 19, 2025

Will Cabaletta Bio Inc. stock split again soonQuarterly Investment Review & AI Based Buy and Sell Signals - DonanımHaber

Dec 19, 2025

Can Cabaletta Bio Inc. stock deliver surprise earnings beatMarket Sentiment Review & Entry and Exit Point Strategies - DonanımHaber

Dec 19, 2025

How Cabaletta Bio Inc. stock benefits from global expansionCPI Data & Expert Curated Trade Setups - bolumsonucanavari.com

Dec 19, 2025

Cabaletta Bio Reports Positive Rese-cel Data Across Myositis, SSc, and SLE Trials - MSN

Dec 19, 2025

Dec 18, 2025

Profit Review: Will Cabaletta Bio Inc. stock recover faster than marketRisk Management & Long Hold Capital Preservation Plans - ulpravda.ru

Dec 18, 2025

Dec 16, 2025

Wells Fargo Downgrades Cabaletta Bio (CABA) - MSN

Dec 16, 2025

Dec 15, 2025

Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? - Yahoo Finance

Dec 15, 2025

Dec 14, 2025

Cabaletta Bio (CABA) price target increased by 15.31% to 14.41 - MSN

Dec 14, 2025

Dec 13, 2025